Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Cannabis Users Choose Qualia Omega-3 To Reset CB1 Receptors

 

 

 


(Medical-NewsWire.com, September 09, 2015 ) San Francisco , California -- Qualia Nutraceuticals has launched the first of what is being called the ‘new generation' of highly potent fish oils, An Omega-3 containing 1500mg of EPA/DHA, making it one of the highest concentrations of fish oil on the market today. Qualia states that of all the health improvements that a highly concentrated Omega-3 can provide, one group of people may experience some of the greatest benefits: the cannabis community.

According to Qualia, long term cannabis users report an increased THC/CBD tolerance and often choose to take a several week (even a month break) from marijuana use in order to get the same, effective ‘high' as they did when they first started using.

Most cannabis users are not aware of the mysterious and critical dependency that Omega-3 levels in the brain play on reducing CB1 tolerance. When present in high enough levels in the brain, Omega-3 actually repairs and replenishes the CB1 receptors responsible for giving users the full THC/CBD effect.

Qualia continues by stating that studies find most users erroneously take a breaks from cannabis use in order to lower and refresh their tolerance levels when they could be supplementing with a highly concentrated Omega-3. Qualia states that "…When people do take these breaks, what they are actually doing is giving their CB1 receptors an opportunity to be repaired by the natural fatty acids that they normally consume on a daily basis."

What if people could replenish the brains CB1 receptors without taking a break?

Qualia's short answer is that cannabis users can do just that. By consuming higher concentrations of EPA DHA rich Omega-3, such as Qualia's Elite 1500mg, Cannabis users can expect to repair CB1 receptors without taking a tolerance break.

Sheila, 19. Colorado:

"After about 3 weeks of Omega-3 use I've noticed a large reduction in the amount of cannabis I need to consume for a positive effect."

Ben, 33. Oregon:

"…I'm interested because I recently started taking 1,500mg two times per day and now I only smoke one bowl a night now instead of a few, and seem to be getting as high, or more. Interesting..."

Brandon, 46. Washington:

"So, I've been taking Omega-3 pills for the last week, and maybe it's just a placebo effect, but I feel like my tolerance has been lowered by a noticeable amount already. This is awesome."

For many years now, Studies have shown the critical connection between CB1 and Omega-3 that consumers are only now starting to confirm. One study published by The National Center for Biotechnology Information in 2011 is supported by these consumer experiences:

"Nutritional Omega-3 Deficiency Abolishes Endocannabinoid-Mediated Neuronal Functions"

"The corollaries of the obesity epidemic that plagues developed societies are malnutrition and resulting biochemical imbalances. Low levels of essential n-3 polyunsaturated fatty acids (n-3 PUFAs) have been linked to neuropsychiatric diseases, but the underlying synaptic alterations are mostly unknown. We found that lifelong n-3 PUFAs dietary insufficiency specifically ablates long-term synaptic depression mediated by endocannabinoids in the prelimbic prefrontal cortex and accumbens. In n-3-deficient mice, presynaptic cannabinoid CB(1) receptors (CB(1)Rs) normally responding to endocannabinoids were uncoupled from their effector G(i/o) proteins. Finally, the dietary-induced reduction of CB(1)R functions in mood-controlling structures was associated with impaired emotional behavior. These findings identify a plausible synaptic substrate for the behavioral alterations caused by the n-3 PUFAs deficiency that is often observed in western diets."

1INSERM U862, Physiopathology of Synaptic Plasticity Group, Neurocentre Magendie, Bordeaux Cedex, France.

Qualia Nutraceuticals states that only by taking an Omega-3 with high enough levels fatty acids (in surplus of 1500mg per serving) can cannabis users hope to achieve a full CB1 reset.

Omega-3 is already highly revered for its anti-depressant aspects, ability to lower cholesterol and other brain benefits but until now, was never seen as a major aide to the cannabis community. Qualia expects that it's highly concentrated Elite Omega-3 will be a huge benefit to all cannabis users by helping to fully restore CB1 receptors without the need for a tolerance break.

About Qualia Nutraceuticals

Qualia believes that great health goes beyond helping people make healthy choices; it's about fostering a connection between people, products and well-being that can only be nourished with trust, openness and care.

Qualia Nutraceuticals

Jenny Sanders

1-860-580-5545

info@qualia-life.com

Source: EmailWire.Com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC